Shandong Xinhua Pharmaceutical Company Limited Class H (XIN) Price & Analysis

Shandong Xinhua Pharmaceutical Company Limited, alongside its subsidiaries, focuses on the conception, production, and commercialization of a diverse array of pharmaceutical and chemical products. Its operations are organized into distinct divisions: Chemical bulk drugs, Pharmaceutical preparations, and Chemical intermediates and Other products. The company's extensive product portfolio encompasses active pharmaceutical ingredients (APIs), finished dosage forms, and various chemical compounds. Under the Xinhua brand, it delivers a wide range of medications, including those for pain and fever (antipyretic analgesics), treatments for cardiovascular and cerebrovascular ailments, anti-infective agents, central nervous system therapies, and numerous other therapeutic solutions. Furthermore, its offerings span prepared Chinese herbal medicine decoctions, traditional Chinese medicines, synthetic pharmaceutical formulations, antibiotics, biochemical drugs, bulk chemical pharmaceuticals, anesthetics, antipsychotics, pharmaceutical precursor chemicals, protein assimilation preparations, peptide hormones, and controlled medical substances, among others. The company also supplies key chemical raw materials like dimethyl sulfate, isobutylbenzene, 1,8-diazabicyclo, undec-7-ene, and tetramethylguanidine. Beyond product manufacturing, Shandong Xinhua Pharmaceutical provides materials and intermediates, and produces diverse dosage forms such as powders for injection, tablets, hard capsules, granules, and dry suspensions. It manages import and export activities for goods and technologies, undertakes medical project planning, and conducts research and development for health products. Additional ventures include certification services, electrical equipment engineering, the installation and testing of chemical and electrical machinery, and the retail of mechanical, hardware, and electrical components. A specialized segment of its business involves the production and distribution of advanced steroid system APIs and intermediates. The firm also offers digital services, including internet data, online sales, and web-based information for pharmaceuticals and medical devices. Its market presence extends across the People's Republic of China, the Americas, Europe, and other global regions. Established in 1943, Shandong Xinhua Pharmaceutical Company Limited is based in Zibo, People's Republic of China.